Archive for June, 2012

First New Prescription Obesity Drug in 13 Years Wins FDA Approval

June 27, 2012 — June 27, 2012 — The Food and Drug Administration announced its approval of lorcaserin today, paving the way for the drug to become only the second prescription obesity treatment available to the roughly one-third of American who have the condition. 

Ted Kyle to Receive Obesity Society Public Service Award

June 20, 2012 — June 20, 2012 — The Obesity Society announced the recipients for their 2012 awards. Honorees include Thomas A. Wadden, PhD, who will receive the TOPS Research Achievement Award; Kevin D. Hall, PhD, who will receive the Lilly Scientific Achievement Award; John G. Kral, MD, PhD, FACS, who will receive the Mickey Stunkard Lifetime Achievement Award; […]